Naz et al., (2004) observed that a majority of prostate cancer cases had serum PSA >20 ng/ml and 50% of BPH cases had serum PSA in the gray zone (4.1-20 ng/ml). The gene discussed is KLK3; the disease is benign prostatic hyperplasia.